National Pharmaceutical Pricing Authority (NPPA) has
brought 80 plus medicines under Price Regulation. NPPA has fixed the
price of 81 medicines including off-patent anti-diabetic drugs allowing
due benefits of patent expiry to the patients.
NPPA has fixed the Retail Price of Insulin Human Injection, 200IU/ml
and 70 per cent Isophane Insulin Human Suspension 30 per cent Insulin
Human Injection 200IU/ml for M/s Wockhardt Ltd at 106.65 rupees per ml
each excluding GST and Prasugrel Hydrochloride 10 mg as film-coated
Aspirin 75 mg as enteric-coated Capsule’for M/s Torrent Pharmaceuticals
Ltd. at 20.16 rupees per Capsule excluding GST with effect from 17th
March 2021.
Both the medicines were being sold at MRP of 132.50 rupees per ml and
at 27.26 rupees per capsule. With this price regulation, NPPA has
re-assured availability of medicines at fair prices to public at large.
NPPA had granted price exemption for above-mentioned formulations to
the companies under Para 32 of the Drug Prices Control Order (DPCO),
2013 for a period of five years due to new drug delivery system
developed through indigenous Research and Development. Price regulation
was not applicable during the exemption period. NPPA in its meeting on
10th of this month decided to regulate the price of these formulations
as per provisions of DPCO, 2013 as the exemption period has been over.
This has resulted in reduction of the prices of Insulin Human
Injection, 200IU/ml and 70 per cent Isophane Insulin Human Suspension
30 per cent Insulin Human Injection 200IU/ml’, causing sizeable
reduction over the existing prices. Now, these medicines have become
more affordable to the public.
NPPA also fixed retail price of 76 new drugs in the meeting dated 10th
of this month to be launched by existing manufacturers including
off-patent Anti-diabetic drugs allowing due benefit of patent expiry to
the patients.
In addition, NPPA fixed ceiling price of 2 scheduled formulation namely
Povidone Iodine 7.5 per cent Scrub an anti-infective formulation and
Levo-Thyroxine 37.5 mg tablet used for treatment of Thyroid related
diseases, causing considerable reduction to their present prices.
Revision in existing ceiling prices of scheduled formulations based on
the Wholesale Price Index (WPI) was also approved by the Authority. The
revised prices will be effective from next month.
Social media is bold.
Social media is young.
Social media raises questions.
Social media is not satisfied with an answer.
Social media looks at the big picture.
Social media is interested in every detail.
social media is curious.
Social media is free.
Social media is irreplaceable.
But never irrelevant.
Social media is you.
(With input from news agency language)
If you like this story, share it with a friend!
We are a non-profit organization. Help us financially to keep our journalism free from government and corporate pressure
0 Comments